Sex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease

Molecular Brain

Volumn 3, Issue 1, 2010, Pages

  Devi, Latha ^a   Alldred, Melissa J ^a,b   Ginsberg, Stephen D ^a,b,c   Ohno, Masuo ^a,b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BETA SECRETASE; BETA SECRETASE 1; ELF2ALPHA PROTEIN; INITIATION FACTOR; MESSENGER RNA; UNCLASSIFIED DRUG; AMYLOID PRECURSOR PROTEIN; ASPARTIC PROTEINASE; BACE1 PROTEIN, MOUSE; SECRETASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIORAL STRESS; BRAIN CORTEX; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE MODEL; DISEASE PREDISPOSITION; FEMALE; HIPPOCAMPUS; IMMOBILIZATION STRESS; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SEX DIFFERENCE; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; ANIMAL BEHAVIOR; BRAIN; GENETICS; HISTOLOGY; HUMAN; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS; MUS MUSCULUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, TRANSGENIC; SEX FACTORS; STRESS, PSYCHOLOGICAL;

EID: 78049462344     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-3-34     Document Type: Article

References (70)

1. Amyloid, the presenilins and Alzheimer's disease. J Hardy, Trends Neurosci 1997 20 154 159 10.1016/S0166-2236(96)01030-2 9106355
2. Alzheimer's disease: genes, proteins, and therapy. DJ Selkoe, Physiol Rev 2001 81 741 766 11274343
3. Alzheimer's disease. K Blennow MJ de Leon H Zetterberg, Lancet 2006 368 387 403 10.1016/S0140-6736(06)69113-7 16876668
4. The environment, epigenetics and amyloidogenesis. J Wu MR Basha NH Zawia, J Mol Neurosci 2008 34 1 7 10.1007/s12031-007-0009-4 18157652
5. Adverse stress, hippocampal networks, and Alzheimer's disease. SM Rothman MP Mattson, Neuromolecular Med 2010 12 56 70 10.1007/s12017-009-8107-9 19943124
6. Proneness to psychological distress and risk of Alzheimer disease in a biracial community. RS Wilson LL Barnes DA Bennett Y Li JL Bienias CF Mendes de Leon DA Evans, Neurology 2005 64 380 382 15668449
7. Chronic psychological distress and risk of Alzheimer's disease in old age. RS Wilson SE Arnold JA Schneider JF Kelly Y Tang DA Bennett, Neuroepidemiology 2006 27 143 153 10.1159/000095761 16974109
8. Chronic stress accelerates learning and memory impairments and increases amyloid deposition in APPV717I-CT100 transgenic mice, an Alzheimer's disease model. YH Jeong CH Park J Yoo KY Shin SM Ahn HS Kim SH Lee PC Emson YH Suh, FASEB J 2006 20 729 731 16467370
9. Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. H Dong B Goico M Martin CA Csernansky A Bertchume JG Csernansky, Neuroscience 2004 127 601 609 10.1016/j.neuroscience.2004.05.040 15283960
10. Corticosterone and related receptor expression are associated with increased -amyloid plaques in isolated Tg2576 mice. H Dong CM Yuede HS Yoo MV Martin C Deal AG Mace JG Csernansky, Neuroscience 2008 155 154 163 10.1016/j.neuroscience.2008.05.017 18571864
11. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress. KW Lee JB Kim JS Seo TK Kim JY Im IS Baek KS Kim JK Lee PL Han, J Neurochem 2009 108 165 175 10.1111/j.1471-4159.2008.05769.x 19012747
12. Sex, hormones, and Alzheimer's disease. LW Baum, J Gerontol A Biol Sci Med Sci 2005 60 736 743 15983176
13. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. K Andersen LJ Launer ME Dewey L Letenneur A Ott JR Copeland JF Dartigues P Kragh-Sorensen M Baldereschi C Brayne A Lobo JM Martinez-Lage T Stijnen A Hofman, Neurology 1999 53 1992 1997 10599770
14. Prevalence of AD among whites: a summary by levels of severity. LX Hy DM Keller, Neurology 2000 55 198 204 10908890
15. The stressed hippocampus, synaptic plasticity and lost memories. JJ Kim DM Diamond, Nat Rev Neurosci 2002 3 453 462 10.1038/nrm832 12042880
16. Sex differences and opposite effects of stress on dendritic spine density in the male versus female hippocampus. TJ Shors C Chua J Falduto, J Neurosci 2001 21 6292 6297 11487652
17. The hippocampus is necessary for enhancements and impairments of learning following stress. DA Bangasser TJ Shors, Nat Neurosci 2007 10 1401 1403 10.1038/nn1973 17906620
18. The basolateral nucleus of the amygdala is necessary to induce the opposing effects of stressful experience on learning in males and females. J Waddell DA Bangasser TJ Shors, J Neurosci 2008 28 5290 5294 10.1523/JNEUROSCI. 1129-08.2008 18480285
19. -Secretase protein and activity are increased in the neocortex in Alzheimer disease. H Fukumoto BS Cheung BT Hyman MC Irizarry, Arch Neurol 2002 59 1381 1389 10.1001/archneur.59.9.1381 12223024
20. Elevated -secretase expression and enzymatic activity detected in sporadic Alzheimer disease. LB Yang K Lindholm R Yan M Citron W Xia XL Yang T Beach L Sue P Wong D Price R Li Y Shen, Nat Med 2003 9 3 4 10.1038/nm0103-3 12514700
21. Amyloid peptide load is correlated with increased -secretase activity in sporadic Alzheimer's disease patients. R Li K Lindholm LB Yang X Yue M Citron R Yan T Beach L Sue M Sabbagh H Cai P Wong D Price Y Shen, Proc Natl Acad Sci USA 2004 101 3632 3637 10.1073/pnas.0205689101 14978286
22. Expression of APP pathway mRNAs and proteins in Alzheimer's disease. T Matsui M Ingelsson H Fukumoto K Ramasamy H Kowa MP Frosch MC Irizarry BT Hyman, Brain Res 2007 1161 116 123 10.1016/j.brainres.2007.05.050 17586478
23. Intraneuronal -amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. H Oakley SL Cole S Logan E Maus P Shao J Craft A Guillozet-Bongaarts M Ohno J Disterhoft L Van Eldik R Berry R Vassar, J Neurosci 2006 26 10129 10140 10.1523/JNEUROSCI.1202-06.2006 17021169
24. Phosphorylation of eukaryotic initiation factor-2 (eIF2) is associated with neuronal degeneration in Alzheimer's disease. RC Chang AK Wong HK Ng J Hugon, Neuroreport 2002 13 2429 2432 10.1097/00001756-200212200-00011 12499843
25. Phosphorylation of the translation initiation factor eIF2 increases BACE1 levels and promotes amyloidogenesis. T O'Connor KR Sadleir E Maus RA Velliquette J Zhao SL Cole WA Eimer B Hitt LA Bembinster S Lammich SF Lichtenthaler SS Hebert B De Strooper C Haass DA Bennett R Vassar, Neuron 2008 60 988 1009 10.1016/j.neuron.2008.10.047 19109907
26. Phospho-eIF2 level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice. L Devi M Ohno, PLoS One 2010 5 12974 10.1371/journal.pone.0012974 20886088
27. A decade of modeling Alzheimer's disease in transgenic mice. E McGowan J Eriksen M Hutton, Trends Genet 2006 22 281 289 10.1016/j.tig.2006.03.007 16567017
28. Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy. J Gotz JR Streffer D David A Schild F Hoerndli L Pennanen P Kurosinski F Chen, Mol Psychiatry 2004 9 664 683 15052274
29. Animal models of Alzheimer's disease and frontotemporal dementia. J Gotz LM Ittner, Nat Rev Neurosci 2008 9 532 544 10.1038/nrn2420 18568014
30. Relevance of transgenic mouse models to human Alzheimer disease. DA Morrissette A Parachikova KN Green FM LaFerla, J Biol Chem 2009 284 6033 6037 10.1074/jbc.R800030200 18948253
31. Alzheimer's disease: insights from epidemiology. I McDowell, Aging (Milano) 2001 13 143 162 11442298
32. Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. C Qiu M Kivipelto E von Strauss, Dialogues Clin Neurosci 2009 11 111 128 19585947
33. The role of amyloid peptide 42 in Alzheimer's disease. MA Findeis, Pharmacol Ther 2007 116 266 286 10.1016/j.pharmthera.2007.06.006 17716740
34. A42 is essential for parenchymal and vascular amyloid deposition in mice. E McGowan F Pickford J Kim L Onstead J Eriksen C Yu L Skipper MP Murphy J Beard P Das K Jansen M Delucia WL Lin G Dolios R Wang CB Eckman DW Dickson M Hutton J Hardy T Golde, Neuron 2005 47 191 199 10.1016/j.neuron.2005.06.030 16039562
35. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid -peptide. C Haass DJ Selkoe, Nat Rev Mol Cell Biol 2007 8 101 112 10.1038/nrm2101 17245412
36. MRI and CSF studies in the early diagnosis of Alzheimer's disease. MJ de Leon S DeSanti R Zinkowski PD Mehta D Pratico S Segal C Clark D Kerkman J DeBernardis J Li L Lair B Reisberg W Tsui H Rusinek, J Intern Med 2004 256 205 223 10.1111/j.1365-2796.2004.01381.x 15324364 (Pubitemid 39222990)
37. Stress and glucocorticoid footprints in the brain-the path from depression to Alzheimer's disease. I Sotiropoulos JJ Cerqueira C Catania A Takashima N Sousa OF Almeida, Neurosci Biobehav Rev 2008 32 1161 1173 10.1016/j.neubiorev.2008.05.007 18573532
38. Estrogen impairs glucocorticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus. MJ Weiser RJ Handa, Neuroscience 2009 159 883 895 10.1016/j.neuroscience.2008.12.058 19166915
39. Towards a molecular understanding of sex differences in memory formation. K Mizuno KP Giese, Trends Neurosci 2010 33 285 291 10.1016/j.tins.2010.03.001 20356635
40. Sex influences on the neurobiology of learning and memory. JM Andreano L Cahill, Learn Mem 2009 16 248 266 10.1101/lm.918309 19318467
41. BACE1 and BACE2 enzymatic activities in Alzheimer's disease. RR Ahmed CJ Holler RL Webb F Li TL Beckett MP Murphy, J Neurochem 2010 112 1045 1053 10.1111/j.1471-4159.2009.06528.x 19968762
42. BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice. M Ohno SL Cole M Yasvoina J Zhao M Citron R Berry JF Disterhoft R Vassar, Neurobiol Dis 2007 26 134 145 10.1016/j.nbd.2006.12.008 17258906
43. -Site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J Zhao Y Fu M Yasvoina P Shao B Hitt T O'Connor S Logan E Maus M Citron R Berry L Binder R Vassar, J Neurosci 2007 27 3639 3649 10.1523/JNEUROSCI.4396-06.2007 17409228
44. -Secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development. X-M Zhang Y Cai K Xiong H Cai X-G Luo J-C Feng RW Clough RG Struble PR Patrylo X-X Yan, Eur J Neurosci 2009 30 2271 2283 10.1111/j.1460-9568.2009.07017.x 20092570
45. Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. G Page A Rioux Bilan S Ingrand C Lafay-Chebassier S Pain MC Perault Pochat C Bouras T Bayer J Hugon, Neuroscience 2006 139 1343 1354 10.1016/j.neuroscience.2006.01.047 16581193
46. Swedish amyloid precursor protein mutation increases phosphorylation of eIF2 in vitro and in vivo. HS Kim Y Choi KY Shin Y Joo YK Lee SY Jung YH Suh JH Kim, J Neurosci Res 2007 85 1528 1537 10.1002/jnr.21267 17393484
47. Transcriptional and translational regulation of BACE1 expression - implications for Alzheimer's disease. S Rossner M Sastre K Bourne SF Lichtenthaler, Prog Neurobiol 2006 79 95 111 10.1016/j.pneurobio.2006.06.001 16904810
48. Transcriptional regulation of -secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Y Wen WH Yu B Maloney J Bailey J Ma I Marie T Maurin L Wang H Figueroa M Herman P Krishnamurthy L Liu E Planel LF Lau DK Lahiri K Duff, Neuron 2008 57 680 690 10.1016/j.neuron.2008.02.024 18341989
49. Gene structure and organization of the human -secretase (BACE) promoter. K Sambamurti R Kinsey B Maloney YW Ge DK Lahiri, FASEB J 2004 18 1034 1036 15059975
50. Glucocorticoids increase amyloid- and tau pathology in a mouse model of Alzheimer's disease. KN Green LM Billings B Roozendaal JL McGaugh FM LaFerla, J Neurosci 2006 26 9047 9056 10.1523/JNEUROSCI.2797-06.2006 16943563
51. BACE1 mRNA Expression in Alzheimer's Disease Postmortem Brain Tissue. DT Coulson N Beyer JG Quinn S Brockbank J Hellemans G Brent R Ravid JA Johnston, J Alzheimers Dis 2010 20930286
52. Increased expression of the amyloid precursor -secretase in Alzheimer's disease. RM Holsinger CA McLean K Beyreuther CL Masters G Evin, Ann Neurol 2002 51 783 786 10.1002/ana.10208 12112088
53. The increased activity of BACE1 correlates with oxidative stress in Alzheimer's disease. R Borghi S Patriarca N Traverso A Piccini D Storace A Garuti C Gabriella O Patrizio T Massimo, Neurobiol Aging 2007 28 1009 1014 10.1016/j.neurobiolaging.2006.05.004 16769154
54. -Secretase (BACE) and GSK-3 mRNA levels in Alzheimer's disease. P Preece DJ Virley M Costandi R Coombes SJ Moss AW Mudge E Jazin NJ Cairns, Brain Res Mol Brain Res 2003 116 155 158 10.1016/S0169-328X(03)00233-X 12941471
55. Aging renders the brain vulnerable to amyloid -protein neurotoxicity. C Geula CK Wu D Saroff A Lorenzo M Yuan BA Yankner, Nat Med 1998 4 827 831 10.1038/nm0798-827 9662375
56. Amyloid- protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. GM Shankar S Li TH Mehta A Garcia-Munoz NE Shepardson I Smith FM Brett MA Farrell MJ Rowan CA Lemere CM Regan DM Walsh BL Sabatini DJ Selkoe, Nat Med 2008 14 837 842 10.1038/nm1782 18568035
57. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. J Nalbantoglu G Tirado-Santiago A Lahsaini J Poirier O Goncalves G Verge F Momoli SA Welner G Massicotte JP Julien ML Shapiro, Nature 1997 387 500 505 10.1038/387500a0 9168112
58. Memory impairment and cholinergic dysfunction by centrally administered A and carboxyl-terminal fragment of Alzheimer's APP in mice. SH Choi CH Park JW Koo JH Seo HS Kim SJ Jeong JH Lee SS Kim YH Suh, FASEB J 2001 15 1816 1818 10.1096/fj.00-0104com 11481240
59. Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein. KW Lee JY Im JS Song SH Lee HJ Lee HY Ha JY Koh BJ Gwag SD Yang SG Paik PL Han, Neurobiol Dis 2006 22 10 24 10.1016/j.nbd.2005.09.011 16289866
60. The amyloidogenic potential and behavioral correlates of stress. C Catania I Sotiropoulos R Silva C Onofri KC Breen N Sousa OF Almeida, Mol Psychiatry 2009 14 95 105 10.1038/sj.mp.4002101 17912249
61. Glucocorticoids increase impairments in learning and memory due to elevated amyloid precursor protein expression and neuronal apoptosis in 12-month old mice. WZ Li WP Li YY Yao W Zhang YY Yin GC Wu HL Gong, Eur J Pharmacol 2010 628 108 115 10.1016/j.ejphar.2009.11.045 19948164
62. Hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease: lack of association between longitudinal and cross-sectional findings. GR Swanwick M Kirby I Bruce F Buggy RF Coen D Coakley BA Lawlor, Am J Psychiatry 1998 155 286 289 9464214
63. High plasma levels of cortisol in patients with senile dementia of the Alzheimer's type. F Masugi T Ogihara K Sakaguchi A Otsuka Y Tsuchiya S Morimoto Y Kumahara S Saeki M Nishide, Methods Find Exp Clin Pharmacol 1989 11 707 710 2560104
64. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. JG Csernansky H Dong AM Fagan L Wang C Xiong DM Holtzman JC Morris, Am J Psychiatry 2006 163 2164 2169 10.1176/appi.ajp.163.12. 2164 17151169
65. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. M Ohno L Chang W Tseng H Oakley M Citron WL Klein R Vassar JF Disterhoft, Eur J Neurosci 2006 23 251 260 10.1111/j.1460-9568.2005.04551.x 16420434
66. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice. R Kimura L Devi M Ohno, J Neurochem 2010 113 248 261 10.1111/j.1471-4159.2010.06608.x 20089133
67. Genetic reductions of -site amyloid precursor protein-cleaving enzyme 1 and amyloid- ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice. L Devi M Ohno, Eur J Neurosci 2010 31 110 118 10.1111/j.1460-9568.2009.07031.x 20092558
68. KBJ Franklin G Paxinos, The Mouse Brain in Stereotaxic Coordinates New York: Academic Press 2008
69. Terminal Continuation (TC) RNA amplification enables expression profiling using minute RNA input obtained from mouse brain. MJ Alldred S Che SD Ginsberg, Int J Mol Sci 2008 9 2091 2104 10.3390/ijms9112091 19165351
70. Transcriptional profiling of small samples in the central nervous system. SD Ginsberg, Methods Mol Biol 2008 439 147 158 18370101